摘要
背景:轻度帕金森综合征(MPS)多见于老年,与脑小血管疾病(SVD)有关,且无单一结果。 目的:探讨大脑中基质金属蛋白酶(MPS)与脑白质高信号(WMH)、腔隙、尾状萎缩和全脑萎缩的横断面关系。 神经系统和认知健康(NCH)的老年人。 方法:对1,219例NCH患者进行常规脑MRI检查。采用统一帕金森病评定量表中的运动部分项目对Trem进行评定。 或者,僵硬,运动迟缓,步态/平衡/轴功能障碍。对尾状萎缩和全脑萎缩分别用双听率和侧脑室脑比进行评估。 很有趣。采用两种视觉评分量表对WMH进行评定。空白也被评定。MPS与血管危险因素/疾病及影像学表现的相关性是通过Logistic再灌注来确定的。 回归分析。 结果:额叶、基底节区腔隙、额叶WMH、尾状萎缩、全脑萎缩与运动迟缓有关。基底节腔隙、尾状萎缩和全脑ATR POY与步态/平衡/轴向功能障碍有关。强直与额叶WMH有关,震颤伴尾状萎缩和全脑萎缩。使用MPS的受试者,表现较少。 在评估全球认知和语言的测试中,没有MPS的汉族受试者。 结论:本研究表明,在NCH衰老个体中,MPS与皮层和皮质下血管及萎缩有关,可能是早期认知的警告信号。 我谢绝了。MPS患者应严格管理大脑SVD,以防止未来的身体和认知障碍。
关键词: 健康老年人,轻度帕金森病征,白质高信号,腔隙,尾状核萎缩,全脑萎缩。
Current Alzheimer Research
Title:Association Between Atrophy of the Caudate Nuclei, Global Brain Atrophy, Cerebral Small Vessel Disease and Mild Parkinsonian Signs in Neurologically and Cognitively Healthy Subjects Aged 45-84 Years: A Crosssectional Study
Volume: 15 Issue: 11
关键词: 健康老年人,轻度帕金森病征,白质高信号,腔隙,尾状核萎缩,全脑萎缩。
摘要: Background: Mild Parkinsonian signs (MPS) are commonly seen in aging, and have been related to cerebral Small Vessel Diseases (SVD) with no univocal results.
Objective: The aim of this study was to investigate the cross-sectional relation between MPS and White Matter Hyperintensities (WMH), lacunes, caudate atrophy, and global cerebral atrophy in a large cohort of Neurologically and Cognitively Healthy (NCH) aging individuals.
Method: 1,219 NCH individuals were included in the analysis, and underwent standard brain MRI. The items of the motor section of the Unified Parkinson’s Disease Rating Scale were used to evaluate tremor, rigidity, bradykinesia, and gait/balance/axial dysfunction. Caudate atrophy and global cerebral atrophy were assessed through the bicaudate ratio and the lateral ventricles to brain ratio, respectively. WMH were assessed through two visual rating scales. Lacunes were also rated. Associations of MPS with vascular risk factors/diseases and imaging findings were determined through the logistic regression analysis.
Results: Frontal and basal ganglia lacunes, frontal WMH, caudate atrophy, and global cerebral atrophy were associated with bradykinesia. Basal ganglia lacunes, caudate atrophy, and global cerebral atrophy were associated with gait/balance/axial dysfunction. Rigidity was associated with frontal WMH, and tremor with caudate atrophy and global cerebral atrophy. NCH subjects with MPS, performed less than subjects without MPS in tests evaluating global cognition and language.
Conclusion: This study demonstrates that in NCH aging individuals, MPS are associated with cortical and subcortical vascular and atrophic changes, and are probably, a warning sign of incipient cognitive decline. Subjects with MPS should manage rigorously cerebral SVD to prevent future physical and cognitive disabilities.
Export Options
About this article
Cite this article as:
Association Between Atrophy of the Caudate Nuclei, Global Brain Atrophy, Cerebral Small Vessel Disease and Mild Parkinsonian Signs in Neurologically and Cognitively Healthy Subjects Aged 45-84 Years: A Crosssectional Study, Current Alzheimer Research 2018; 15 (11) . https://dx.doi.org/10.2174/1567205015666180702111110
DOI https://dx.doi.org/10.2174/1567205015666180702111110 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Adenosine A2A Receptors in Psychopharmacology: Modulators of Behavior, Mood and Cognition
Current Neuropharmacology Antagonists of the Vasopressin V1 Receptor and of the β<sub>1</sub>-Adrenoceptor Inhibit Cytotoxic Brain Edema in Stroke by Effects on Astrocytes-but the Mechanisms Differ
Current Neuropharmacology Suppression of Glial HO-1 Activitiy as a Potential Neurotherapeutic Intervention in AD
Current Alzheimer Research Purinergic Receptors and Pain
Current Pharmaceutical Design Targeting Kinin Receptors for the Treatment of Neurological Diseases
Current Pharmaceutical Design Neuronal Nitric Oxide Synthase and Sympathetic Nerve Activity in Neurovascular and Metabolic Systems
Current Neurovascular Research Substance P in Rheumatic Diseases
Current Rheumatology Reviews Role of the Endocannabinoid System in the Neuroendocrine Responses to Inflammation
Current Pharmaceutical Design Dopaminergic Enhancement of Cognitive Function
Current Pharmaceutical Design Connecting the Brain and New Drug Targets for Schizophrenia
Current Pharmaceutical Design Implications of Parkinson’s Disease Pathophysiology for the Development of Cell Replacement Strategies and Drug Discovery in Neurodegenerative Diseases
CNS & Neurological Disorders - Drug Targets Pharmacoproteomics Applications for Drug Target Discovery in CNS Disorders
Current Pharmacogenomics and Personalized Medicine In Vitro and In Vivo Models of Multiple Sclerosis
CNS & Neurological Disorders - Drug Targets Editorial (Thematic Issue: Cocaine and Amphetamine-Type Stimulants: the Search for Pharmacological Therapies)
Current Pharmaceutical Design Cognitive Dysfunction in FMR1 Premutation Carriers
Current Psychiatry Reviews Cannabinoid Signaling in Glial Cells in Health and Disease
Current Neuropharmacology The Vpu Protein and its Role in HIV-1 Pathogenesis
Current Genomics Postmortem-Assessed Impairment of Neuronal Activity in Depression: The Dominant Impact of Suicide
CNS & Neurological Disorders - Drug Targets Potential Mechanisms of Failure in the Sudden Infant Death Syndrome
Current Pediatric Reviews Cytokine-Purine Interactions in Traumatic Stress, Behavioral Depression,and Sickness
CNS & Neurological Disorders - Drug Targets